AAAAAA

   
Results: 1-18 |
Results: 18
Formation of novel photodimers from 4-aryl-1,4-dihydropyridines
Authors: Hilgeroth, A Baumeister, U
Citation: A. Hilgeroth et U. Baumeister, Formation of novel photodimers from 4-aryl-1,4-dihydropyridines, CHEM-EUR J, 7(21), 2001, pp. 4599-4603
Regioselective formation of novel functionalized 1-aza-9-oxafluorenes
Authors: Hilgeroth, A Brachwitz, K Baumeister, U
Citation: A. Hilgeroth et al., Regioselective formation of novel functionalized 1-aza-9-oxafluorenes, HETEROCYCLE, 55(4), 2001, pp. 661-669
Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors
Authors: Hilgeroth, A Billich, A Lilie, H
Citation: A. Hilgeroth et al., Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors, EUR J MED C, 36(4), 2001, pp. 367-374
Solution-dimerization of 4-aryl-1,4-dihydropyridines
Authors: Hilgeroth, A Baumeister, U Heinemann, FW
Citation: A. Hilgeroth et al., Solution-dimerization of 4-aryl-1,4-dihydropyridines, EUR J ORG C, (2), 2000, pp. 245-249
The first functionalized 6,12-diazatetrakishomocubanes
Authors: Hilgeroth, A Baumeister, U
Citation: A. Hilgeroth et U. Baumeister, The first functionalized 6,12-diazatetrakishomocubanes, ANGEW CHEM, 39(3), 2000, pp. 576-578
Bioanalysis of syn dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H19: Metabolic and cytotoxic properties in Hep G2 cells
Authors: Hilgeroth, A Langner, A
Citation: A. Hilgeroth et A. Langner, Bioanalysis of syn dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H19: Metabolic and cytotoxic properties in Hep G2 cells, ARCH PHARM, 333(6), 2000, pp. 195-197
First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: Biotransformation and toxicity on Hep G2 cells
Authors: Hilgeroth, A Langner, A
Citation: A. Hilgeroth et A. Langner, First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: Biotransformation and toxicity on Hep G2 cells, ARCH PHARM, 333(1), 2000, pp. 32-34
Plasma protein binding properties of dimeric 4-aryl-1,4-dihydropyridines as novel non peptidic HIV-1 protease inhibitors
Authors: Hilgeroth, A Langner, A
Citation: A. Hilgeroth et A. Langner, Plasma protein binding properties of dimeric 4-aryl-1,4-dihydropyridines as novel non peptidic HIV-1 protease inhibitors, PHARMAZIE, 55(7), 2000, pp. 542-543
Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors - affinities to intestinal P-glycoprotein
Authors: Hilgeroth, A Dressler, C Neuhoff, S Spahn-Langguth, H Langguth, P
Citation: A. Hilgeroth et al., Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors - affinities to intestinal P-glycoprotein, PHARMAZIE, 55(10), 2000, pp. 784-785
Solid-state photodimerization of 4-aryl-1,4-dihydropyridines studied by C-13 CPMAS NMR spectroscopy
Authors: Hilgeroth, A Hempel, G Baumeister, U Reichert, D
Citation: A. Hilgeroth et al., Solid-state photodimerization of 4-aryl-1,4-dihydropyridines studied by C-13 CPMAS NMR spectroscopy, SOL ST NUCL, 13(4), 1999, pp. 231-243
Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cagedimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representativeof a novel class of HIV-1 protease inhibitors: A molecular modeling study
Authors: Hilgeroth, A Fleischer, R Wiese, M Heinemann, FW
Citation: A. Hilgeroth et al., Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cagedimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representativeof a novel class of HIV-1 protease inhibitors: A molecular modeling study, J COMPUT A, 13(3), 1999, pp. 233-242
Solid-state formation of centrosymmetric cage dimeric 4-aryl-1,4-dihydropyridines via non-symmetric syn-dimers studied by C-13 cross-polarization magic angle spinning NMR spectroscopy
Authors: Hilgeroth, A Hempel, G Baumeister, U Reichert, D
Citation: A. Hilgeroth et al., Solid-state formation of centrosymmetric cage dimeric 4-aryl-1,4-dihydropyridines via non-symmetric syn-dimers studied by C-13 cross-polarization magic angle spinning NMR spectroscopy, MAGN RES CH, 37(5), 1999, pp. 376-381
Rotameric properties of novel N-acyl and N-acyloxy dimeric 4-phenyl-1,4-dihydropridines derived from developed solid-state synthesis
Authors: Hilgeroth, A Baumeister, U Heinemann, F
Citation: A. Hilgeroth et al., Rotameric properties of novel N-acyl and N-acyloxy dimeric 4-phenyl-1,4-dihydropridines derived from developed solid-state synthesis, HETEROCYCLE, 51(10), 1999, pp. 2367-2376
Cage dimeric N-acyl- and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors
Authors: Hilgeroth, A Billich, A
Citation: A. Hilgeroth et A. Billich, Cage dimeric N-acyl- and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors, ARCH PHARM, 332(11), 1999, pp. 380-384
Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors
Authors: Hilgeroth, A Billich, A
Citation: A. Hilgeroth et A. Billich, Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors, ARCH PHARM, 332(1), 1999, pp. 3-5
Topochemical investigations of dimerizing 4-aryl-1,4-dihydropyridines by X-ray crystal structure analysis.
Authors: Hilgeroth, A Baumeister, U Heinemann, FW
Citation: A. Hilgeroth et al., Topochemical investigations of dimerizing 4-aryl-1,4-dihydropyridines by X-ray crystal structure analysis., J MOL STRUC, 474, 1999, pp. 267-274
Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors
Authors: Hilgeroth, A Wiese, M Billich, A
Citation: A. Hilgeroth et al., Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors, J MED CHEM, 42(22), 1999, pp. 4729-4732
Recent advances in the solid-state photochemistry of 1,4-dihydropyridines
Authors: Hilgeroth, A
Citation: A. Hilgeroth, Recent advances in the solid-state photochemistry of 1,4-dihydropyridines, RRD PURE AP, 3, 1999, pp. 153-159
Risultati: 1-18 |